Daniel L. Barber

Daniel L. Barber

Auto-generated profile, based on publicly available information

Daniel L. Barber

T Lymphocyte Biology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
SSShunsuke Sakai
Shunsuke Sakai
KKKeith D. Kauffman
Keith D. Kauffman
JSJason M. Schenkel
Jason M. Schenkel
CMCortez C. McBerry
Cortez C. McBerry
KMKatrin D. Mayer-Barber
Katrin D. Mayer-Barber
DBDaniel L. Barber
Daniel L. Barber
Th1 cells are critical for containment of Mycobacterium tuberculosis infection, but little else is known about the properties of protective CD4 T cell responses. In this study, we show that the pulmonary Th1 response against M. tuberculosis is composed of two populations that are either CXCR3hi and localize to lung parenchyma or are CX3CR1hiKLRG1hi and are retained within lung blood vasculature. M. tuberculosis–specific parenchymal CD4 T cells migrate rapidly back into the lung parenchyma upon adoptive transfer, whereas the intravascular effectors produce the highest levels of IFN-γ in vivo. Importantly, parenchymal T cells displayed greater control of infection compared with the intravascular counterparts upon transfer into susceptible T cell–deficient hosts. Thus, we identified a subset of naturally generated M. tuberculosis–specific CD4 T cells with enhanced protective capacity and showed that control of M. tuberculosis correlates with the ability of CD4 T cells to efficiently enter the lung parenchyma rather than produce high levels of IFN-γ.

31 May 2016 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
SSShunsuke Sakai
Shunsuke Sakai
KKKeith D. Kauffman
Keith D. Kauffman
MSMichelle A. Sallin
Michelle A. Sallin
ASArlene H. Sharpe
Arlene H. Sharpe
HYHoward Young
Howard Young
DBDaniel L. Barber
Daniel L. Barber
IFN-γ–producing CD4 T cells are required for protection against Mycobacterium tuberculosis (Mtb) infection, but the extent to which IFN-γ contributes to overall CD4 T cell-mediated protection remains unclear. Furthermore, it is not known if increasing IFN-γ production by CD4 T cells is desirable in Mtb infection. Here we show that IFN-γ accounts for only ~30% of CD4 T cell-dependent cumulative bacterial control in the lungs over the first six weeks of infection, but >80% of control in the spleen. Moreover, increasing the IFN-γ–producing capacity of CD4 T cells by ~2 fold exacerbates lung infection and leads to the early death of the host, despite enhancing control in the spleen. In addition, we show that the inhibitory receptor PD-1 facilitates host resistance to Mtb by preventing the detrimental over-production of IFN-γ by CD4 T cells. Specifically, PD-1 suppressed the parenchymal accumulation of and pathogenic IFN-γ production by the CXCR3+KLRG1-CX3CR1- subset of lung-homing CD4 T cells that otherwise mediates control of Mtb infection. Therefore, the primary role for T cell-derived IFN-γ in Mtb infection is at extra-pulmonary sites, and the host-protective subset of CD4 T cells requires negative regulation of IFN-γ production by PD-1 to prevent lethal immune-mediated pathology. The development of novel tuberculosis vaccines has been hindered by the poor understanding of the mechanisms of host-protection. It has been long-held that IFN-γ is the principle effector of CD4 T cell-mediated resistance to Mtb infection, but Mtb-specific CD4 T cells produce low amounts of IFN-γ in vivo, leading to the possibility that increasing IFN-γ production by Th1 cells might enhance control of Mtb infection. However, the precise contribution of IFN-γ to CD4 T cell-dependent protection and the outcome of increasing IFN-γ production by CD4 T cells have not been evaluated. Here we show that IFN-γ accounts for only ~30% of the cumulative CD4 T cell-mediated reduction in lung bacterial loads over the first 1.5 months of infection. Moreover, we find that increasing the per capita production of IFN-γ by CD4 T cells leads to the early death of the host. Lastly, we show that suppression of CD4 T cell-derived IFN-γ by the inhibitory receptor PD-1 is essential to prevent lethal disease. Therefore, poor control Mtb infection does not result from defective production of IFN-γ, and strategies to selectively boost it are unwarranted. Furthermore, identifying the primary mechanisms of CD4 T cell-dependent control of Mtb infection should be a priority.

1 February 2011 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
DBDaniel L. Barber
Daniel L. Barber
KMKatrin D. Mayer-Barber
Katrin D. Mayer-Barber
CFCarl G. Feng
Carl G. Feng
ASArlene H. Sharpe
Arlene H. Sharpe
ASAlan Sher
Alan Sher
Although CD4 T cells are required for host resistance to Mycobacterium tuberculosis, they may also contribute to pathology. In this study, we examine the role of the inhibitory receptor PD-1 and its ligand PD-L1 during M. tuberculosis infection. After aerosol exposure, PD-1 knockout (KO) mice develop high numbers of M. tuberculosis-specific CD4 T cells but display markedly increased susceptibility to infection. Importantly, we show that CD4 T cells themselves drive the increased bacterial loads and pathology seen in infected PD-1 KO mice, and PD-1 deficiency in CD4 T cells is sufficient to trigger early mortality. PD-L1 KO mice also display enhanced albeit less severe susceptibility, indicating that T cells are regulated by multiple PD ligands during M. tuberculosis infection. M. tuberculosis-specific CD8 T cell responses were normal in PD-1 KO mice, and CD8 T cells only had a minor contribution to the exacerbated disease in the M. tuberculosis-infected PD-1 KO and PD-L1 KO mice. Thus, in the absence of the PD-1 pathway, M. tuberculosis benefits from CD4 T cell responses, and host resistance requires inhibition by PD-1 to prevent T cell-driven exacerbation of the infection.

16 January 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
DBDaniel L. Barber
Daniel L. Barber
SSShunsuke Sakai
Shunsuke Sakai
RKRagini R. Kudchadkar
Ragini R. Kudchadkar
SFSteven P. Fling
Steven P. Fling
TDTracey A. Day
Tracey A. Day
ESElad Sharon
Elad Sharon
Increased Mtb-specific T H 1 responses precede tuberculosis associated with PD-1 blockade.

17 July 2015 in Cold Spring Harbor Perspectives in Medicine
Verified
Journal Article
Open access
PDF file
KMKatrin D. Mayer-Barber
Katrin D. Mayer-Barber
DBDaniel L. Barber
Daniel L. Barber
Host resistance to Mycobacterium tuberculosis (Mtb) infection requires the coordinated efforts of innate and adaptive immune cells. Diverse pulmonary myeloid cell populations respond to Mtb with unique contributions to both host-protective and potentially detrimental inflammation. Although multiple cell types of the adaptive immune system respond to Mtb infection, CD4 T cells are the principal antigen-specific cells responsible for containment of Mtb infection, but they can also be major contributors to disease during Mtb infection in several different settings. Here, we will discuss the role of different myeloid populations as well as the dual nature of CD4 T cells in Mtb infection with a primary focus on data generated using in vivo cellular immunological studies in experimental animal models and in humans when available.

8 January 2021 in Science Immunology
Verified
Journal Article
Closed access
KKKeith D. Kauffman
Keith D. Kauffman
SSShunsuke Sakai
Shunsuke Sakai
NLNickiana E. Lora
Nickiana E. Lora
SNSivaranjani Namasivayam
Sivaranjani Namasivayam
PBPaul J. Baker
Paul J. Baker
DBDaniel L. Barber
Daniel L. Barber
Blockade of the PD-1 coinhibitory pathway compromises immune control of Mycobacterium tuberculosis infection in rhesus macaques.